|
|
|
 |
FDA Approval Activities for this Drug…
Boniva (ibandronate sodium) Tablets, Hoffmann-La Roche NDA 21-455 | Boniva (ibandronate sodium) Tablets, Hoffmann-La Roche, New Dosage Regimen | Boniva (ibandronate sodium) Injection, Hoffmann-La Roche, Approval | Boniva (ibandronate sodium) Injection, Hoffmann-La Roche, Approval | Boniva (ibandronate sodium) Tablets, Hoffmann-La Roche, Labeling Revision | Boniva (ibandronate sodium) Injection, Hoffmann-La Roche, Labeling Revision | Boniva (ibandronate sodium) Tablets, Hoffmann-La Roche, Labeling Revision | Boniva (ibandronate sodium) Injection, Hoffmann-La Roche, Labeling Revision | Boniva (ibandronate sodium) Tablets, Hoffman-La Roche, Inc., New or Modified Indication | Boniva (ibandronate sodium) Tablets, Hoffman-La Roche, Inc., New or Modified Indication | Ibandronate Sodium Injection, Teva Parenteral Medicines, Inc., Tentative Approval | Ibandronate Sodium Tablets, Cobalt Laboratories Inc., Tentative Approval | Boniva (ibandronate sodium) Tablets, Hoffmann-La Roche, Inc., Labeling Revision | Ibandronate Sodium Tablets, Orchid Healthcare, Tentative Approval | Ibandronate Sodium Tablets, Cobalt Laboratories, Inc., Tentative Approval | Ibandronate Sodium Tablets, Mylan Pharmaceuticals, Inc., Tentative Approval | Ibandronate Sodium Injection, Sun Pharmaceutical Industries, Ltd., Tentative Approval | Boniva (ibandronate sodium) Injection, Hoffmann-La Roche, Inc., Labeling Revision | Boniva (ibandronate sodium) Tablets, Hoffman-La Roche, Inc., Labeling Revision | Ibandronate Sodium Tablets, Watson Laboratories, Inc., Tentative Approval | Boniva (ibandronate sodium) Injection, Hoffmann-La Roche, Inc., Labeling Revision | Boniva (ibandronate sodium) Intravenous Injection, Hoffmann-La Roche, Inc., Labeling Revision | Ibandronate Sodium Tablets, Mutual Pharmaceutical, Tentative Approval
  
|